Biotechnology Theriva Biologics Hits Several Milestones In 2023, Positioning Itself For Growth As The Firm Targets Difficult-To-Treat Cancers – Theriva Biologics (AMEX:TOVX) Read more
Biotechnology US Intelligence Claims Chinese Pharma Giant Illegally Shared Secrets With Beijing – WuXi Biologics (Cayman) (OTC:WXIBF) Read more
Biotechnology Swiss Healthcare Manufacturing Firm Lonza Bolsters Biologics Manufacturing Capacity With Roche’s US Facility Acquisition For $1.2B – Roche Holding (OTC:RHHBY) Read more
Stockmarkets Lonza to buy biologics site from Roche in U.S. for $1.2 billion Reuters via biedexmarkets.com Read more
Biotechnology How Theriva Biologics Is Using An Adenovirus To Develop A Novel Treatment For Pancreatic Cancer, As Well As Other Cancers With An Unmet Need – Theriva Biologics (AMEX:TOVX) Read more
Biotechnology Qu Biologics and TransBIOTech Awarded $450K Applied Research and Development Grant Funding Read more
Biotechnology Could This Common Virus Unlock New Cancer Treatments? Theriva Biologics Believes That Adenoviruses Could Be Instrumental In The Next Evolution Of Oncology – Candel Therapeutics (NASDAQ:CADL), CG Oncology (NASDAQ:CGON) Read more
Opinion Thinking about buying stock in Evaxion Biotech, Macy’s, Ford Motor, Marvell Technology, or Turnstone Biologics? – Ford Motor (NYSE:F), Evaxion Biotech (NASDAQ:EVAX) Read more